Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2387 (116th)

STOP GAMES Act of 2019

openUnited States· United States Congress· EN

Introduced

29 April 2019

Last action

13 November 2019 · Committee

Status

Forwarded by Subcommittee to Full Committee by Voice Vote .

Sponsors

Rep. Levin, Andy [D-MI-9], Rep. Rooney, Francis [R-FL-19], Rep. Doggett, Lloyd [D-TX-37], Rep. Tonko, Paul [D-NY-20], Rep. Garamendi, John [D-CA-8], Rep. Khanna, Ro [D-CA-17], Rep. Johnson, Eddie Bernice [D-TX-30], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Green, Al [D-TX-9], Rep. Axne, Cynthia [D-IA-3], Rep. Tlaib, Rashida [D-MI-12], Sen. Welch, Peter [D-VT]

Subjects

Healthcare

Source updated

7 April 2025

Healthcare

Summary

Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon Act of 2019 or the STOP GAMES Act of 2019 This bill specifies factors that the Food and Drug Administration (FDA) must use in determining if a petition is submitted with the primary purpose of delaying the approval of a pending new or generic drug application. (Current law allows third parties, including interested parties, to file petitions asking the FDA to take various actions, such as to consider certain issues pertaining to an application for market approval for a drug; current law also allows the FDA to deny a petition that is submitted with the primary purpose of delaying approval of an application.) The factors include (1) whether the petitioner filed serial petitions raising issues that could have been known to the petitioner when an earlier petition was filed, and (2) whether the petition has any data or information to support its scientific positions. If the FDA finds that delay is the primary purpose of the petition, it must refer the matter to the Federal Trade Commission. A party filing a petition must do so within 60 days of when the party first learned of the information on which the petition is based.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 29 April 2019

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 29 April 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 29 April 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 30 April 2019

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 13 November 2019

    Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote .

    Source: Committee

  6. 13 November 2019

    Committee

    Subcommittee Consideration and Mark-up Session Held.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 29 April 2019

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 29 April 2019

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 29 April 2019

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.